Hepatic encephalopathy

被引:0
|
作者
Kircheis, G. [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, Moorenstr 5, D-40225 Dusseldorf, Germany
来源
GASTROENTEROLOGE | 2007年 / 2卷 / 04期
关键词
Hepatic Encephalopathy; Astrocyte swelling; Psychometric tests; Oscillatory networks; Critical flicker frequency; Treatment precipitating factors;
D O I
10.1007/s11377-007-0088-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatic encephalopathy (HE) is a neuropsychiatric disorder which can appear as a complication of acute or chronic liver disorders. Pathophysiologically the disorder is a clinical manifestation of a low-grade chronic cerebral edema, which leads to changes in astrocytic function with disturbances of glioneuronal communication. The findings point to a disturbance of cerebral oscillatory networks in HE that is triggered by possible neurotoxic- and hydration-sensitive, thalamic structures and results in an abnormally low-frequency and rigid thalamocortical and corticomuscular coupling. While the diagnosis of high-grade HE will be done exclusively by the clinical picture, psychometric and neurophysiological tests are necessary to diagnose the low-grade forms. Yet, the analysis of the critical flicker frequency (CFF) has been shown to be an easy and simple semi-quantitative test procedure for the quantification and follow-up of neuropsychiatric deficits in HE. The recognition and consequent treatment of the precipitating factors are the most important therapeutic measures. These are complemented by dietetic and pharmaceutical treatment.
引用
收藏
页码:251 / 260
页数:10
相关论文
共 50 条
  • [41] Nutrition in Hepatic Encephalopathy
    Chadalavada, Rajagopal
    Biyyani, Raja Shekhar Sappati
    Maxwell, John
    Mullen, Kevin
    NUTRITION IN CLINICAL PRACTICE, 2010, 25 (03) : 257 - 264
  • [42] Using saccades to diagnose covert hepatic encephalopathy
    Cunniffe, Nicholas
    Munby, Henry
    Chan, Shona
    Saatci, Defne
    Edison, Eric
    Carpenter, R. H. S.
    Massey, Dunecan
    METABOLIC BRAIN DISEASE, 2015, 30 (03) : 821 - 828
  • [43] Pharmacotherapy for Hepatic Encephalopathy
    Paula V. Phongsamran
    Jiwon W. Kim
    Jennifer Cupo Abbott
    Angela Rosenblatt
    Drugs, 2010, 70 : 1131 - 1148
  • [44] Hepatic Encephalopathy and Melatonin
    Arjunan, Archana
    Sah, Dhiraj Kumar
    Jung, Young Do
    Song, Juhyun
    ANTIOXIDANTS, 2022, 11 (05)
  • [45] Management of Hepatic Encephalopathy
    Frontera, Jennifer A.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2014, 16 (06) : 1 - 37
  • [46] OVERVIEW OF HEPATIC ENCEPHALOPATHY
    Ibrahim, Muhammed
    Aldhubayban, Hissah Naif
    Jobah, Salem Hisham Salem
    Alharbi, Faris Abdullah S.
    Alotaibi, Mohammed Hamed
    Alsaedi, Hani Mabrouk
    Alyami, Thamer Hassan R.
    Alhaeti, Haitham Rasheed
    Alshubini, Aqeela Saad
    Alnefaie, Rakan Abdullah
    Alqarni, Zahi Mohammed
    Albaqshi, Ali Khader
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (02): : 3484 - 3490
  • [47] The treatment of hepatic encephalopathy
    Marsha Y. Morgan
    A. Blei
    K. Grüngreiff
    R. Jalan
    G. Kircheis
    G. Marchesini
    O. Riggio
    Karin Weissenborn
    Metabolic Brain Disease, 2007, 22 : 389 - 405
  • [48] Management of Hepatic Encephalopathy
    Jennifer A. Frontera
    Current Treatment Options in Neurology, 2014, 16
  • [49] Pathogenesis of Hepatic Encephalopathy in Chronic Liver Disease
    Ochoa-Sanchez, Rafael
    Rose, Christopher F.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 8 (03) : 262 - 271
  • [50] Minimal hepatic encephalopathy
    Stewart, Charmaine A.
    Smith, Glenn E.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2007, 4 (12): : 677 - 685